SCHEMBL4800748

SCHEMBL4800748

O=C(O)c1ccc(OCCCO/N=C/c2cn(Cc3ccccc3)c3ccccc23)cc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MAPT P10636 3/20 0.50
HPGD P15428 2/20 0.50
POLB P06746 4/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
CASP6 P55212 1/20 0.49
RCE1 Q9Y256 1/20 0.49
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
SENP7 Q9BQF6 1/20 0.47
GCGR P47871 2/20 0.47
PLA2G2A P14555 3/20 0.47
GAA P10253 2/20 0.46
BACE1 P56817 1/20 0.46
THRB P10828 1/20 0.44
ABCC2 Q92887 1/20 0.43
PPARG P37231 1/20 0.43
PPARD Q03181 1/20 0.43
PPARA Q07869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4800762 1.00 ALDH1A1 (0.50) ALDH1A1MAPTHPGDPOLBMEN1
SCHEMBL4800513 0.92 MAPT (0.52) ALDH1A1MAPTHPGDPOLBMEN1
SCHEMBL4798983 0.92 MAPT (0.52) ALDH1A1MAPTHPGDPOLBMEN1
SCHEMBL4799000 0.92 MAPT (0.52) ALDH1A1MAPTHPGDPOLBMEN1
SCHEMBL4798169 0.81 MAPT (0.45) ALDH1A1MAPTHPGDPOLBMEN1
SCHEMBL4798181 0.81 MAPT (0.45) ALDH1A1MAPTHPGDPOLBMEN1
SCHEMBL4798722 0.79 MAOB (0.43) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL4798713 0.79 MAOB (0.43) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL4798224 0.78 ALDH1A1 (0.54) ALDH1A1MAPTHPGDPOLBMEN1
SCHEMBL4797184 0.78 KMT2A (0.50) ALDH1A1MAPTHPGDPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342039-B2 Substituted indole oximes WYETH (US) 2008-03-11 US claimed
US-20050119326-A1 Substituted aryloximes WYETH (US) 2005-06-02 US claimed
US-7342039-B2 Substituted indole oximes WYETH (US) 2008-03-11 US disclosed
US-20050119326-A1 Substituted aryloximes WYETH (US) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119326-A1 Substituted aryloximes IDO2, TDO2, IDO1 ALDH1A1 304/4885MAPT 4402/4885HPGD 364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.